UMIN ID: UMIN000001841
Registered date:02/04/2009
A randomized, double blind, comparative study of vitamin D3 versus placebo in patients with Parkinson disease aged between 45 and 85 years old to improve neurological signs and quality of life
Basic Information
Recruitment status | Complete: follow-up complete |
---|---|
Health condition(s) or Problem(s) studied | Parkinson disease |
Date of first enrollment | 2009/04/01 |
Target sample size | 120 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | Vitamin D3 placebo |
Outcome(s)
Primary Outcome | changes of UPDRS, HY stage, MMSE |
---|---|
Secondary Outcome | changes of PDQ-39 and EQ-5D |
Key inclusion & exclusion criteria
Age minimum | 45years-old |
---|---|
Age maximum | 85years-old |
Gender | Male and Female |
Include criteria | |
Exclude criteria | 1. Already taking vitamin D supplement or 1,25 vitamin D 2. History of kidney stone 3. Familial or early onset (< 55 years old) type of Parkinson disease 4. Osteoporosis 5. Other difficulties judged by the physician in charge |
Related Information
Primary Sponsor | Jikei University School of Medicine |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | Jikei University School of Medicine |
Secondary ID(s) |
Contact
public contact | |
Name | Emi Suzuki |
Address | Japan |
Telephone | |
urashima@jikei.ac.jp | |
Affiliation | Jikei University School of Medicine Division of Molecular Epidemiology |
scientific contact | |
Name | Mitsuyoshi Urashima |
Address | 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo 105-8461, Japan Japan |
Telephone | 03-3433-1111 |
Affiliation | Jikei University School of Medicine Division of Molecular Epidemiology |